MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate

Juanni Liu1, Junhai Li1, Yongtu Ma2

  • 1Department of Oncology, NO.215 Hospital of shaanXi Nuclear Industry, Xianyang City, Shanxi Province, China.

Bioengineered
|July 9, 2021
PubMed

Insights

MicroRNAs (miRNAs) like miR-145-5p are vital in prostate cancer (PCa) progression. This study found miR-145-5p inhibits PCa cell growth and metastasis by targeting PLD5, offering potential therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Prostate cancer (PCa) remains a significant global health concern, particularly in its metastatic stages.
  • MicroRNAs (miRNAs) play critical roles in regulating cellular processes, including cancer development and progression.

Purpose of the Study:

  • To investigate the association between miR-145-5p and PLD5 in prostate cancer.
  • To elucidate the functional role of miR-145-5p in regulating PCa cell proliferation, migration, and invasion.

Main Methods:

  • Utilized PCa cell lines (PC-3, LNCaP, DU-145) and a non-cancerous cell line (RWPE-1).
  • Assessed miRNA and gene expression via RT-qPCR, and protein binding using dual-luciferase reporter assays.
  • Evaluated cell proliferation, migration, and invasion using MTT, scratch wound, and transwell assays, respectively.

Main Results:

  • miR-145-5p was found to be downregulated in PCa cell lines and tissues.
  • Overexpression of PLD5 promoted cancerous effects, while miR-145-5p mimicry reversed these effects.
  • miR-145-5p significantly inhibited PCa cell proliferation, migration, invasion, and metastasis.

Conclusions:

  • miR-145-5p acts as a tumor suppressor in prostate cancer.
  • miR-145-5p upregulates apoptosis and represses migration, invasion, and metastasis by directly modulating PLD5.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K